超声引导下经皮射频消融治疗肾脏肿瘤  

Treatment of renal tumors with ultrasound-guided percutaneous radiofrequency ablation

作　　者：张士伟[1] 李笑弓[1] 张古田[1] 甘卫东[1] 汪维[1] 燕翔[1] 刘光香[1] 纪长威[1] 连惠波[1] 郭宏骞[1] 

机构地区：[1]南京大学医学院附属鼓楼医院泌尿外科,210008

出　　处：《江苏医药》2010年第19期2243-2245,I0001,共4页Jiangsu Medical Journal

基　　金：江苏省卫生厅指导性项目(Z200712)

摘　　要：目的总结经皮超声引导下射频消融术治疗肾脏肿瘤的临床效果。方法 19例肿瘤位于肾脏背外侧、肾中下极的患者接受B超引导经皮射频消融术。结果 19例手术均获成功。手术时间30～50min,无肾周出血、肾周积液、邻近脏器损伤等并发症。术后住院2～5d。病理诊断:肾细胞癌14例,肾脏错构瘤3例,2例病理无法判断。1例术后复查证实肿瘤残留,再次行经皮射频治疗。随访5～19个月,尚未发现肿瘤局部复发或者远处转移。结论超声引导下经皮射频消融术治疗肾脏肿瘤具有创伤小、术后恢复快等优点。对于肿瘤位于肾脏背外侧且中下极不适宜或者不愿手术患者是一种可供选择的微创治疗方法。Objective To summarize the outcomes of treating renal tumors with ultrasound-guided percutaneous radiofrequency ablation（RFA）.Methods Ninteen consecutive patients with renal tumors located in the dorsolateral zone or middle and low pole of the kidney underwent ultrasound-guided percutaneous RFA.Results The operations in all patients were successful without serious complications of perirenal hemorrhage,effusion and injury on adjacent organs.The time of operation was 30 to 50 minutes and hospital stay was 2 to 5 days.Pathological diagnosis was renal cell carcinoma（RCC ） in 14 cases,renal hamartoma in 3 cases and no definite agnosis in 2 case. One patient was confirmed having residual tumor by review,who recieved second percutaneous RFA. There were no cases with local tumor recurrence or distant metastasis during follow-up for 5 to 19 months.ConclusionUltrasound-guided percutaneous RFA of renal tumors has the advantages of less trauma and rapid postoperative recovery and is a good choice of minimally invasive treatment method for the tumors located in the dorsolateral zone or middle and low pole of the kidney that is unsuitable for surgery or unwilling to receive operation.

关 键 词：射频消融 超声 肾肿瘤 

分 类 号：R737[医药卫生—肿瘤]